The specific price of Belumosudil in the market

Belumosudil mesylate tablets (Belumosudil) is a new type of oral small molecule kinase inhibitor. Its mechanism of action is mainly through inhibiting the Rho-associated serine/threonine kinase (ROCK) pathway, regulating the immune response and fibrosis process, thereby exerting a therapeutic effect on chronic graft-versus-host disease (cGvHD) and other fibrosis-related diseases.

Besudil's unique target gives it obvious advantages in controlling immune cell activity, reducing inflammatory response and improving tissue fibrosis, providing a new treatment option for patients with long-term refractorycGvHD. In clinical applications, besudil can help patients reduce symptoms of multi-organ involvement such as skin, liver and mucous membranes, while improving quality of life and providing an alternative for patients who cannot tolerate traditional immunosuppressive therapy.

In terms of market price, Besudil has been approved for marketing in China and has been included in the medical insurance management. The domestic trade name is Besudil Mesylate Tablets (ReZUROCK/REZUROCK). The common specification is 0.2g*30 tablets, and each box sells for about 10,000 to 20,000 yuan. The price is relatively high. However, after being included in medical insurance, some patients can obtain financial support through medical insurance reimbursement, reducing the burden of treatment. In comparison, the overseas original research version is more expensive, with each box selling for more than 10,000 US dollars, which fluctuates significantly due to exchange rates and market factors. There are also imitation versions on the overseas market. For example, Besudil of the same specification produced by Lucius Pharmaceutical Factory in Laos sells for about 4,000 yuan per box. Its drug ingredients are consistent with the original version, providing a viable option for patients with limited financial ability.

In general, besudil, as a newROCK inhibitor, has clear therapeutic effects and targeting mechanisms, and is available in both domestic and foreign markets. Imported brand-name drugs are more expensive, while generic versions provide patients with a lower-cost option.

Reference: https://www.drugs.com/pro/rezurock.html